Ionis Pharma
IONS----
Ionis Pharma (IONS)
Ionis Pharmaceuticals, Inc., a commercial-stage biotechnology company, provides RNA-targeted medicines in the United States. The company offers TRYNGOLZA reduce...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Ionis Pharma Analyst Rating
View MoreForecast & Rating
Jul 22, 2026Price forecast
$92.0070.34%
Forecast & RatingBuy
22analysts
- Strong buy45.45%
- Buy40.91%
- Hold13.64%
- Sell0.00%
- Strong sell0.00%
News
- Tip Ranks · 12 hours ago
Ionis Maintains Buy Rating as Olezarsen’s sHTG Profile Outshines Rival; $86 Price Target Reaffirmed
- Price Alert · 15 hours ago
Pre-market hot trades in US stocks: Ionis Pharma pre-market down 10.21%; Fluence Energy pre-market up 7.26%
- benzinga_article · Jul 16 at 06:15 AM
This Etsy Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday
- StockTitan · Jul 14 at 10:05 PM
Ionis to hold second quarter 2026 financial results webcast | IONS Stock News
- Unusual Whales · Jul 14 at 11:50 AM
Biogen Slumps As Alzheimer's Study Leaves 'More Questions Than Answers'
- StockTitan · Jul 14 at 12:16 AM
Ionis Partner Biogen Presents Phase 2 CELIA Data at AAIC Demonstrating Meaningful Clinical Outcomes and Robust Tau Reduction with Diranersen in Early Alzheimer’s Disease | IONS Stock News
